Search results
MindMed discovers, develops, and deploys psychedelic-inspired medicines to improve health, promote wellness, and alleviate suffering. Learn more about our medicines and therapies today.
- Clinical Trials
You can also visit the Suicide Prevention Lifeline website....
- Programs & Research
In clinical trials, MM120 has shown positive effects in...
- Investors
Mind Medicine (MindMed) Inc. One World Trade Center Suite...
- About Us
Professor of Psychiatry and Medicine at Tufts University...
- News & Media
View All Presentations. Email Alerts. Sign up for email...
- Careers
MindMed’s team works virtually around the world, combining...
- Contact Us
MindMed US Headquarters. One World Trade Center Suite 8500...
- Clinical Trials
Mind Medicine Australia is a charity that seeks to alleviate the suffering caused by mental illness in Australia through expanding the treatment options available.
This online Mindfulness-Based Stress Reduction (MBSR) course is 100% free, created by a fully certified MBSR instructor, and is based on the program founded by Jon Kabat-Zinn at the University of Massachusetts Medical School.
Find free video instruction in individual mind-body practices, self-care webinars, and an invitation to join Mind-Body Skills Groups. Mind-Body Resources Scholarships provide training in trauma healing and resilience building to communities and individuals around the globe.
Explore evidence-based mind-body techniques with these free, guided practices led by our Founder and CEO, James S. Gordon, MD. Learn more about the science and practical application of mind-body approaches through these expert-led webinars on a variety of topics.
Programs to help you work through chronic pain. View a new free resource for learning about Mind-Body conditions. Recent report on our work, quoting Mark Lumley, on NPRs Morning Edition. Listen or read the transcript of this report regarding the use of Emotional Awareness and Expression Therapy for chronic pain. Click here.
Mind Medicine (MindMed) Inc., doing business as MindMed, is a New York-based biotechnology company that is currently developing clinical and therapeutic applications for psychedelic and, more broadly, psychoplastogenic drugs.
